Literature DB >> 14976431

Monoubiquitination: the signal for p53 nuclear export?

Christopher L Brooks1, Muyang Li, Wei Gu.   

Abstract

The ubiquitin-proteasome pathway has become an increasingly important regulatory mechanism for protein function. Countless proteins are degraded by the addition of polymeric ubiquitin chains, but more recently, monoubiquitination has emerged as a mechanism for regulatory functions other than proteasomal degradation. Monoubiquitination acts as a signal in nuclear export for the tumor suppressor protein p53. Different levels of Mdm2 are capable of inducing both mono- and polyubiquitination in a dosage dependent manner, thus determining p53's fate. Our findings demonstrate monoubiquitin-mediated protein trafficking can be expanded to nuclear-cytoplasmic shuttling, and also imply similar scenarios may apply to other cellular factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14976431

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  18 in total

1.  ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation.

Authors:  Remy Pedeux; Sagar Sengupta; Jiang Cheng Shen; Oleg N Demidov; Shin'ichi Saito; Hitoshi Onogi; Kensuke Kumamoto; Stephen Wincovitch; Susan H Garfield; Mary McMenamin; Makoto Nagashima; Steven R Grossman; Ettore Appella; Curtis C Harris
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 2.  No Splicing, no dicing: non-proteolytic roles of the ubiquitin-proteasome system in transcription.

Authors:  Thomas Kodadek
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

3.  Non-proteolytic regulation of p53-mediated transcription through destabilization of the activator.promoter complex by the proteasomal ATPases.

Authors:  Young-Chan Kim; Shwu-Yuan Wu; Hyun-Suk Lim; Cheng-Ming Chiang; Thomas Kodadek
Journal:  J Biol Chem       Date:  2009-10-21       Impact factor: 5.157

Review 4.  Balanced ubiquitination determines cellular responsiveness to extracellular stimuli.

Authors:  Akiko Mukai; Miki Yamamoto-Hino; Masayuki Komada; Hideyuki Okano; Satoshi Goto
Journal:  Cell Mol Life Sci       Date:  2012-07-24       Impact factor: 9.261

Review 5.  The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors.

Authors:  Mario Di Napoli; BethAnn McLaughlin
Journal:  Curr Opin Investig Drugs       Date:  2005-07

6.  White spot syndrome virus open reading frame 222 encodes a viral E3 ligase and mediates degradation of a host tumor suppressor via ubiquitination.

Authors:  Fang He; Beau J Fenner; Andrew K Godwin; Jimmy Kwang
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 7.  Targeting the ubiquitin system in cancer therapy.

Authors:  Daniela Hoeller; Ivan Dikic
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

8.  Glioblastoma development in mouse brain: general reduction of OCTs and mislocalization of OCT3 transporter and subsequent uptake of ASP+ substrate to the nuclei.

Authors:  Lilia Y Kucheryavykh; Kimberleve Rolón-Reyes; Yuriy V Kucheryavykh; Serguei Skatchkov; Misty J Eaton; Priscila Sanabria; William D Wessinger; Mikhail Inyushin
Journal:  J Neurosci Neuroeng       Date:  2014-02

9.  CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.

Authors:  Dingding Shi; Marius S Pop; Roman Kulikov; Ian M Love; Andrew L Kung; Andrew Kung; Steven R Grossman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-04       Impact factor: 11.205

10.  Regulation of transcriptional activators by DNA-binding domain ubiquitination.

Authors:  Vivien Landré; Bhindu Revi; Maria Gil Mir; Chandra Verma; Ted R Hupp; Nick Gilbert; Kathryn L Ball
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.